| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |